TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,544,000 | -59.4% | 57,513 | -27.8% | 0.00% | -66.7% |
| Q4 2021 | $3,802,000 | +1.1% | 79,703 | +40.8% | 0.00% | -25.0% |
| Q3 2021 | $3,761,000 | +15.5% | 56,609 | +11.0% | 0.00% | +33.3% |
| Q2 2021 | $3,255,000 | -34.0% | 51,009 | -2.2% | 0.00% | -50.0% |
| Q1 2021 | $4,934,000 | -15.7% | 52,160 | +8.6% | 0.01% | -14.3% |
| Q4 2020 | $5,854,000 | +89.0% | 48,041 | +35.4% | 0.01% | +75.0% |
| Q3 2020 | $3,098,000 | +35.2% | 35,468 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $2,291,000 | +72.1% | 35,468 | +19.0% | 0.00% | +50.0% |
| Q1 2020 | $1,331,000 | -19.7% | 29,804 | +12.0% | 0.00% | 0.0% |
| Q4 2019 | $1,657,000 | +89.4% | 26,604 | +14.3% | 0.00% | +100.0% |
| Q3 2019 | $875,000 | – | 23,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |